Veralox Therapeutics is a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs.

Biotechnology

Veralox Therapeutics

Veralox Therapeutics' headquarters in Frederick, MD, United States

Jonathan Mow

Michael Hanna

David J. Maloney

Matthew B. Boxer

Raghu Mirmira

Jim Trenkle

Ted Holman

Adam Cuker

Peter Young

Jamie Stiff

Steven Mckenzie

Ben Scruggs

Gowthami Arepally

Alex Martin

Steven Zelenkofske

Megan Krench

The Scientific Advisors at Veralox Therapeutics play a crucial role in guiding the company’s research and development efforts. They leverage their deep expertise in drug discovery and disease mechanisms to provide strategic input on the design of clinical trials, help identify potential therapeutic targets, and evaluate the scientific validity of innovative therapeutic approaches. Their insights ensure that Veralox remains at the forefront of addressing significant unmet medical needs.

Scientific Advisors

The Leadership Team at Veralox Therapeutics guides the strategic direction and operational execution of the company, ensuring alignment with its mission to develop innovative small molecule therapeutics. This multidisciplinary team, comprising experts in science, operations, and medical research, collaborates to drive clinical advancements, oversee translational research efforts, and manage the integration of scientific discoveries into viable treatment options for patients with unmet medical needs.

Leadership Team

Veralox Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Veralox Therapeutics

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Related companies